Professor of Surgery Chief, Surgical Oncology Wake Forest University
General Surgery
Dr. Edward F. Levine, MD
|
|
Give Review
Edward F. Levine works in the field of General Surgery. He has 4 awards "America's Top Doctors for Cancer", "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Dr. Edward F. Levine is a published doctor and has 100 publications published. The lastest was: 'Stage-Specific Prognostic Effect of Race in Patients with Resectable Gastric Adenocarcinoma: An 8-Institution Study of the US Gastric Cancer Collaborative.' Edward Levine accepts Medicare payments and is registered with Medicare.gov.
Publications
- Stoma Creation and Reversal After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
- Conditional Survival After Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Low- and High-Grade Appendiceal Primaries.
- Is the Combination of Distal Pancreatectomy and Cytoreductive Surgery With HIPEC Reasonable?: Results of an International Multicenter Study.
- Stage-Specific Prognostic Effect of Race in Patients with Resectable Gastric Adenocarcinoma: An 8-Institution Study of the US Gastric Cancer Collaborative.
- Routine Admission to Intensive Care Unit After Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy: Not Always a Requirement.
- Incidence of Perioperative Complications Following Resection of Adrenocortical Carcinoma and Its Association with Long-Term Survival.
- Is Linitis Plastica a Contraindication for Surgical Resection: A Multi-Institution Study of the U.S. Gastric Cancer Collaborative.
- Gastric remnant cancer: A distinct entity or simply another proximal gastric cancer?
- Outcomes of Gastric Cancer Resection in Octogenarians: A Multi-institutional Study of the U.S. Gastric Cancer Collaborative.
- Changing pattern in malignant mesothelioma survival.
- Prognostic Performance of Different Lymph Node Staging Systems After Curative Intent Resection for Gastric Adenocarcinoma.
- Factors Associated With Recurrence and Survival in Lymph Node-Negative Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer Collaborative.
- Significance of diabetes on morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
- Utility of the proximal margin frozen section for resection of gastric adenocarcinoma: a 7-Institution Study of the US Gastric Cancer Collaborative.
- A Nomogram to Predict Overall Survival and Disease-Free Survival After Curative Resection of Gastric Adenocarcinoma.
- Can the Risk of Non-home Discharge After Resection of Gastric Adenocarcinoma Be Predicted: a Seven-Institution Study of the US Gastric Cancer Collaborative.
- Conditional Survival after Surgical Resection of Gastric Cancer: A Multi-Institutional Analysis of the US Gastric Cancer Collaborative.
- Is It Time to Abandon the 5-cm Margin Rule During Resection of Distal Gastric Adenocarcinoma? A Multi-Institution Study of the U.S. Gastric Cancer Collaborative.
- Peritoneal Surface Disease (PSD) from Appendiceal Cancer Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Overview of 48...
- Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis.
- Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in sarcomatosis from gastrointestinal stromal tumor.
- Significance of Diaphragmatic Resections and Thoracic Chemoperfusion on Outcomes of Peritoneal Surface Disease Treated with Cytoreductive Surgery (CRS) and Hyperthermi...
- Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for gallbladder cancer: a retrospective review.
- Combined Genetic and Nutritional Risk Models of Triple Negative Breast Cancer.
- Significance of signet ring cells in high-grade mucinous adenocarcinoma of the peritoneum from appendiceal origin.
- Metastatic Colorectal Cancer: Survival Comparison of Hepatic Resection Versus Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
- Phase II Trial of Adjuvant Oral Thalidomide Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Disease from Colorecta...
- Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
- Significance of Urinary Tract Involvement in Patients Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
- Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbid...
- Efficacy of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in the Management of Malignant Ascites.
- Obesity and Peritoneal Surface Disease: Outcomes after Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Appendiceal and Colon Primary Tumors.
- Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in...
- Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal sarcomatosis.
- Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma.
- Predicting Postoperative Morbidity Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CS+HIPEC) with Preoperative FACT-C (Functional Asses...
- Optimal timing of systemic therapy in resectable colorectal liver metastases.
- Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from rectal cancer.
- Race and recurrence in women who undergo neoadjuvant chemotherapy for breast cancer.
- Current status and future directions in appendiceal cancer with peritoneal dissemination.
- Patient rated outcomes and survivorship following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS + HIPEC).
- A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C.
- Contralateral prophylactic mastectomy in breast cancer patients who test negative for BRCA mutations.
- Is Intraoperative Imprint Cytology Evaluation Still Feasible for the Evaluation of Sentinel Lymph Nodes for Lobular Carcinoma of the Breast?
- Management of peritoneal carcinomatosis from colorectal cancer.
- Genetic Polymorphisms of Multiple DNA Repair Pathways Impact Age at Diagnosis and TP53 Mutations in Breast Cancer.
- Survival and Quality of Life Following Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colonic Origin.
- Outcomes of immediate breast reconstruction in patients undergoing single-stage sentinel lymph node biopsy and mastectomy.
- Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface dissemination from ovarian neoplasms.
- Erratum: Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy for Malignant Peritoneal Mesothelioma: Mitomycin Versus Cisplatin.
- Primary leiomyosarcoma of the inferior vena cava: A 2-institution analysis of outcomes.
- Use of FDG-PET imaging for patients with disseminated cancer of the appendix.
- The American Society of Peritoneal Surface Malignancies (ASPSM).
- Outcomes of patients with esophageal cancer staged with [¹â¸F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the u...
- Sentinel lymph node intraoperative imprint cytology in patients with breast cancer-costly or cost effective?
- Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for malignant peritoneal mesothelioma: mitomycin versus cisplatin.
- Outcome after mastectomy for ipsilateral breast tumor recurrence after breast conserving surgery.
- Initial institutional experience with thoracoscopic assisted esophagectomy.
- Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER-O registry.
- Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.
- Outcomes associated with cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in colorectal cancer patients with peritoneal surface Disease and hepatic ...
- Sentinel lymph node mapping for gastric adenocarcinoma.
- Impact of sentinel lymph node biopsy on immediate breast reconstruction after mastectomy.
- Intraoperative imprint cytology for evaluation of sentinel lymph nodes from Merkel cell carcinoma.
- Recurrence after mastectomy for ductal carcinoma in situ.
- Translation considerations for hyperthermic intraperitoneal chemotherapy.
- Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: non-colorectal indications.
- Does shave biopsy accurately predict the final breslow depth of primary cutaneous melanoma?
- The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer with peritoneal surface Disease.
- The current role of hyperthermic intraperitoneal chemotherapy for peritoneal dissemination of appendiceal tumors.
- Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy: overview and rationale.
- Adenocarcinoma of the appendix is rarely detected by colonoscopy.
- Uterine leiomyosarcoma metastatic to soft tissue of the flank following a ten-year Disease-free interval.
- Peritoneal surface Disease from colorectal cancer: comparison with the hepatic metastases surgical paradigm in optimally resected patients.
- The randomized trial of cytoreductive surgery with hyperthermic intraperitoneal chemoperfusion: what it does and does not tell us.
- Health system correlates of receipt of radiation therapy after breast-conserving surgery: a study of low-income Medicaid-enrolled women.
- A phase I trial of oxaliplatin for intraperitoneal hyperthermic chemoperfusion for the treatment of peritoneal surface dissemination from colorectal and appendiceal ca...
- Polymorphisms in drug metabolism genes, smoking, and p53 mutations in breast cancer.
- Patterns of care analysis among women with ductal carcinoma in situ in North Carolina.
- Survival and health outcomes after cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of appendiceal origin.
- Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities.
- Treatment of in-transit metastases from Merkel cell carcinoma with isolated hyperthermic limb perfusion.
- Appendiceal carcinoma with peritoneal dissemination: outcomes for the best of the best.
- Cytomorphologic features of primary peritoneal mesothelioma in effusion, washing, and fine-needle aspiration biopsy specimens: examination of 49 cases at one instituti...
- Use of sentinel lymph node biopsy for melanoma of the head and neck.
- Intraperitoneal hyperthermic chemotherapy using carboplatin: a phase I analysis in ovarian carcinoma.
- Male breast cancer during treatment with leuprolide for prostate cancer.
- Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.
- Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures.
- Pathologic correlation study of microwave coagulation therapy for hepatic malignancies using a three-ring probe.
- Monitoring health outcomes following cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis.
- Pleuropulmonary involvement in pseudomyxoma peritonei: morphologic assessment and literature review.
- Sentinel lymph node biopsy during pregnancy: initial clinical experience.
- Racial differences in patterns of care among medicaid-enrolled patients with breast cancer.
- Use of sentinel node mapping for cancer of the colon: 'to map or not to map".
- Intraperitoneal hemorrhage in a patient with hepatic focal nodular hyperplasia.
- Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review.
- Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy.
- Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment ...
Schools
David Geffen School Of Medicine At UCLA University Of California Los Angeles
University Of California Los Angeles
University Miss Med Center
Procedures Preformed
- Non-Coronary Angioplasty, Atherectomy, and Stenting
- Thromboendarterectomy or Excision of Infected Graft
- Ultrasound, Carotid
- Vascular Duplex Ultrasonography and Plethysmography
Conditions Treated
- Abdominal Aortic Aneurysm (AAA)
- Aortic Aneurysm
- Carotid Artery Disease
- Peripheral Arterial Aneurysm and Dissection
- View All
Doctors Specialties
- General Surgery
- Vascular Surgery
Accepted Insurances
Awards
- America's Top Doctors for Cancer
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
Rosalind Franklin University of Medicine and Science
Drug Facts
| NPI NUMBER | 1275518334 | |
| NPPES Provider LastName | LEVINE | |
| NPPES Provider FirstName | EDWARD | |
| NPPES Provider ZIPCode | 271570001 | |
| NPPES Provider State | NC | |
| Specialty Description | General Surgery | |
| Total Claim Count | 134.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 27.0 | |
| Percent Opioid Claims | 20.15 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1275518334 |
| Last Name Of The Provider | LEVINE |
| First Name Of The Provider | EDWARD |
| View All |
Similar Doctors
|
Dr. Robert E. McCoy, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Clarence R. Petrie, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Stephen M. Wilson, MD |
|
|
Dr. Steven R. Posner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ernest Wagner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward M. Zohman, MD |
|
|
Dr. Stephen M. Kubaska III, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Bernard P. Novak, MD
This Doctor is OpenDoctor Recommended.
|